Bioquell, part of Ecolab, is helping pharmaceutical companies to resume operations post COVID-19

Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity

As the world prepares to enter the next phase of the COVID-19 pandemic with the increasing relaxation of lockdown restrictions, Bioquell, an Ecolab solution and leading manufacturer of high performance bio-decontamination technology, is utilising its well-proven Rapid Bio Decontamination Service (RBDS) to help pharmaceutical companies ensure operational continuity and quickly ramp up capacity.

The fully managed and inclusive RBDS solution, which utilises the company’s scientifically proven 35% hydrogen peroxide vapour technology, provides microbiologically clean surfaces and spaces.

It is backed by an excellent track record of use in spaces impacted by pathogens including SARS, EBOLA, MERS-CoV and SARS CoV-2 across a range of life science and healthcare environments.

Bioquell RBDS can be used to effectively decontaminate newly constructed spaces prior to occupation or production areas after a scheduled maintenance to ensure there are no remaining contaminants that might impact operations.

As a result, it will enable pharmaceutical companies that have reduced production during the coronavirus pandemic to quickly gain control of clean spaces and return to full capacity.

Bioquell RBDS is a fully managed service that enables pharmaceutical businesses to retain or recover the microbial integrity of critical areas such as clean rooms and research laboratories.

Bioquell’s hydrogen peroxide vapour is a vapour-phase disinfection method that is virucidal on structurally distinct viruses dried on surfaces. It achieves a level of efficacy against a wide range of micro-organisms unmatched by standard cleaning practices and other disinfection technologies.

It is uniform across the entire target area and not limited to line-of-sight or easy-to-reach spaces. The process is residue-free, proven safe on sensitive electronics and shown to kill a broad spectrum of micro-organisms including bacteria, viruses, fungi, spores and more.

Bioquell RBDS can be quickly called upon to eradicate coronavirus and other bioburden from a single area, several locations within a facility or an entire building.

The service is fully operated by Bioquell’s expert team of biodecontamination specialists allowing on-site staff to focus on the other activities need to restore operation. In some cases, decontamination can be completed in as little as 24 hours enabling a rapid return to production.

It offers the flexibility to retain or recover the microbial integrity of critical areas with every deployment including planning, co-ordination, setup, equipment, and cycle validation and verification.

It provides a complete final report confirming a 6-log kill of the spaces and surfaces that have been treated with the use of biological and chemical indicators.

Companies